Hytrin (Terazosin Hydrochloride) - Summary

HYTRIN SUMMARY

HYTRIN®
(terazosin hydrochloride)

HYTRIN (terazosin hydrochloride) is an alpha-1-selective adrenoceptor blocking agent.

HYTRIN (terazosin hydrochloride) is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with HYTRIN. The long-term effects of HYTRIN on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined.

HYTRIN is also indicated for the treatment of hypertension. It can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.

HYTRIN NEWS HIGHLIGHTS

Published Studies Related to Hytrin (Terazosin)

Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial. [2008.04]

Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study. [2007.03.05]

More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study. [2006]

Comparative evaluation of Prostina and terazosin in the treatment of benign prostatic hyperplasia. [2005.02]

Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. [2004.11]

more>>

Clinical Trials Related to Hytrin (Terazosin)

Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension [Completed]

Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up [Terminated]

Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin [Recruiting]

Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating [Recruiting]

Alpha-Blocker Plus Diuretic Combination Therapy as Second-Line Treatment for Nocturia in Men [Completed]

more>>